相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab
Zi-Zhen Xu et al.
ANNALS OF HEMATOLOGY (2013)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia
Naoto Morishita et al.
PEDIATRIC BLOOD & CANCER (2012)
Treatment for metastatic nasopharyngeal carcinoma
Y. Bensouda et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2011)
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
Barbara Adamo et al.
BREAST CANCER RESEARCH (2011)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non-Small Cell Lung Cancer
Akihiko Yoshizawa et al.
CLINICAL CANCER RESEARCH (2010)
From man to mouse and back again: advances in defining tumor AKTivities in vivo
David F. Restuccia et al.
DISEASE MODELS & MECHANISMS (2010)
Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
Sara M. Johnson et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma
Jing Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein
M. R. Abedini et al.
ONCOGENE (2010)
mTOR: dissecting regulation and mechanism of action to understand human disease
Deborah C. I. Goberdhan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
Hyun Goo Woo et al.
CANCER RESEARCH (2009)
The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray
Li Xiao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Nasopharyngeal carcinoma - Review of the molecular mechanisms of tumorigenesis
Josephine Chou et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Nasopharyngeal carcinoma: molecular biomarker discovery and progress
William Chi-shing Cho
MOLECULAR CANCER (2007)
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2007)
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
Josep Castellvi et al.
CANCER (2006)
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma
Christopher E. Pelloski et al.
CLINICAL CANCER RESEARCH (2006)
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling
Markus J. Riemenschneider et al.
CANCER RESEARCH (2006)
Molecularly targeted therapy for gastrointestinal cancer
MW Wiedmann et al.
CURRENT CANCER DRUG TARGETS (2005)
PI3K/Akt/mTOR pathway as a target for cancer therapy
D Morgensztern et al.
ANTI-CANCER DRUGS (2005)
Signaling control of mRNA translation in cancer pathogenesis
EC Holland et al.
ONCOGENE (2004)
Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities
I Topisirovic et al.
CANCER RESEARCH (2004)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)